MAPK13 anticorps (Middle Region)
Aperçu rapide pour MAPK13 anticorps (Middle Region) (ABIN928853)
Antigène
Voir toutes MAPK13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Purification
- Purified
-
Immunogène
- MAPK13 antibody was raised in rabbit using the middle region of MAPK13 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
MAPK13 Blocking Peptide, (ABIN937976), is also available for use as a blocking control in assays to test for specificity of this MAPK13 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- MAPK13 (Mitogen-Activated Protein Kinase 13 (MAPK13))
-
Autre désignation
- MAPK13
-
Sujet
- The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is closely related to p38 MAP kinase, both of which can be activated by proinflammatory cytokines and cellular stress. MAP kinase kinases 3, and 6 can phosphorylate and activate this kinase. Transcription factor ATF2, and microtubule dynamics regulator stathmin have been shown to be the substrates of this kinase. Synonyms: Polyclonal MAPK13 antibody, Anti-MAPK13 antibody, mitogen-activated protein kinase 13 antibody, MGC99536 antibody, PRKM13 antibody, SAPK4 antibody, p38delta antibody.
-
Pathways
- Signalisation MAPK, Neurotrophin Signaling Pathway, Hepatitis C, BCR Signaling, S100 Proteins
Antigène
-